<DOC>
	<DOCNO>NCT00748592</DOCNO>
	<brief_summary>This randomize , double-blind , placebo-controlled , multicenter trial 4-way crossover design . Elderly subject primary insomnia meet screening requirement initially randomize study receive first 4 treatment ( PD 0200390 5 mg , 15 mg 30 mg placebo ) daily 30 minute bed time 2 consecutive day polysomnography ( PSG ) lab .</brief_summary>
	<brief_title>A Dose-Ranging , Multicenter Polysomnography Trial PD 0200390 Elderly Subjects With Primary Insomnia</brief_title>
	<detailed_description />
	<mesh_term>Sleep Initiation Maintenance Disorders</mesh_term>
	<criteria>3 month history primary insomnia Difficulty initiate maintain sleep least 3 nights/week past month ( difficulty fall asleep , difficulty stay asleep , early awakening ) Any history psychiatric diagnosis History presence breathing related sleep disorder History presence medical neurological condition could interfere sleep Use alcohol sleep aid 2 standard drink consume per day 14 consume per week</criteria>
	<gender>All</gender>
	<minimum_age>65 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2009</verification_date>
	<keyword>Insomnia , Primary Insomnia , Chronic Insomnia , DIMS ( Disorders Initiating Maintaining Sleep ) , Disorders Initiating Maintaining Sleep</keyword>
</DOC>